Cargando…

Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small cell lung cancer (SCLC) and poor prognosis

Detalles Bibliográficos
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1996
Materias:	Errata
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074734/

Ejemplares similares

Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small-cell lung cancer (SCLC) and poor prognosis. Medical Research Council Lung Cancer Working Party.
Publicado: (1996)

Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): a combined multivariable analysis on data from nine centres
Publicado: (1996)

Erratum: Up-regulation of LINC00161 correlates with tumor migration and invasion and poor prognosis of patients with hepatocellular carcinoma
por: Xu, Li-Chao, et al.
Publicado: (2019)

Halifax Union Poor-Law Hospital
Publicado: (1914)

Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanisms
por: Abdi, Jahangir, et al.
Publicado: (2013)

Erratum. Clinical Translation of Cardiovascular Outcome Trials in Type 2 Diabetes: Is There More or Is There Less Than Meets the Eye? Diabetes Care 2021;44:641–646
por: Ferrannini, Ele, et al.
Publicado: (2021)

Incretin Therapy and Pancreatic Pathologies: Background Pathology Versus Drug-Induced Pathology in Rats. Diabetes 2014;63:1174–1178
por: Egan, Josephine M., et al.
Publicado: (2014)

Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy
por: Fanotto, Valentina, et al.
Publicado: (2018)

Prognosis and long-term outcomes of acute kidney injury due to snake envenomation
por: Priyamvada, P S, et al.
Publicado: (2020)

Chemotherapy- and Immune-Related Gene Panel in Prognosis Prediction and Immune Microenvironment of SCLC
por: Chen, Meng-Yu, et al.
Publicado: (2022)

Erratum for: Transforming operating rooms into intensive care units and the versatility of the physician anesthesiologist during the COVID-19 crisis
Publicado: (2020)

Spatiotemporal trends and prognosis of end stage renal disease patients with biopsy-proven IgA nephropathy in France, 2010–2014
por: Robert, Thomas, et al.
Publicado: (2020)

Erratum. Mitigating Cardiovascular Risk in Type 2 Diabetes With Antidiabetes Drugs: A Review of Principal Cardiovascular Outcome Results of EMPA-REG OUTCOME, LEADER, and SUSTAIN-6 Trials. Diabetes Care 2017;40:821–831
por: Kaul, Sanjay
Publicado: (2018)

Oaks JJ, Santhanam R, Walker CJ, et al. Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies. Blood. 2013;122(11):1923-1934.
Publicado: (2014)

Erratum. Intensive Versus Standard Blood Pressure Control in SPRINT-Eligible Participants of ACCORD-BP. Diabetes Care 2017;40:1733–1738
por: Buckley, Leo F., et al.
Publicado: (2018)

Erratum: Changes in expression levels of ERCC1, DPYD, and VEGFA mRNA after first-line chemotherapy of metastatic colorectal cancer: results of a multicenter study
por: Baba, Hideo, et al.
Publicado: (2015)

Erratum. Combination Therapy With Exenatide Plus Pioglitazone Versus Basal/Bolus Insulin in Patients With Poorly Controlled Type 2 Diabetes on Sulfonylurea Plus Metformin: The Qatar Study. Diabetes Care 2017;40:325–331
por: Abdul-Ghani, Muhammad, et al.
Publicado: (2017)

Corrigenda for four articles
por: Li, Qiang
Publicado: (2015)

Cho B-S, Zeng Z, Mu H, et al. Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy. Blood. 2015;126(2):222-232.
Publicado: (2015)

Understanding SCLC heterogeneity and plasticity in cancer metastasis and chemotherapy resistance: Understanding SCLC heterogeneity and plasticity in metastasis and chemoresistance
por: Jin, Yujuan, et al.
Publicado: (2023)

Mode of binding of the antithyroid drug propylthiouracil to mammalian haem peroxidases. Erratum
por: Singh, R. P., et al.
Publicado: (2015)

Small Renal Mass with Sarcomatoid Features: Erratum
Publicado: (2021)

Antimicrobial resistance inStaphylococcus pseudintermedius and the molecular epidemiology of methicillin-resistantS. pseudintermedius in small animals in Finland
por: Grönthal, Thomas, et al.
Publicado: (2017)

Erratum for Characterization of the intestinal mucosal proteome in cats with inflammatory bowel disease and alimentary small cell lymphoma
Publicado: (2021)

Erratum: Disruption of Myc-Max Heterodimerization with Improved Cell-Penetrating Analogs of the Small Molecule 10074-G5
por: Wang, Huabo, et al.
Publicado: (2018)

Is transformed small cell lung cancer (SCLC) different from de novo SCLC?
por: Park, Cheol-Kyu, et al.
Publicado: (2019)

Erratum. Small Fiber Neuropathy in Patients With Latent Autoimmune Diabetes in Adults. Diabetes Care 2015;38:e102–e103
por: Alam, Uazman, et al.
Publicado: (2015)

Clinicopathological Difference and Survival Impact of Patients with c-SCLC and SCLC
por: Zhang, Chenyue, et al.
Publicado: (2021)

Elevated Expression of the RAGE Variant-V in SCLC Mitigates the Effect of Chemotherapeutic Drugs
por: Madhavan, Bindhu K., et al.
Publicado: (2021)

Tumor-Targeted Drug Conjugates as an Emerging Novel Therapeutic Approach in Small Cell Lung Cancer (SCLC)
por: Deneka, Alexander Y., et al.
Publicado: (2019)

Survival, Chemotherapy and Chemosensitivity Predicted by CTC Cultured In Vitro of SCLC Patients
por: Ju, Lixia, et al.
Publicado: (2021)

A randomised trial of low-dose/high-frequency chemotherapy as palliative treatment of poor-prognosis small-cell lung cancer: a Cancer research Campaign trial.
por: James, L. E., et al.
Publicado: (1996)

Sonic Hedgehog in SCLC
por: Laukkanen, Mikko O., et al.
Publicado: (2015)

Pathology and Classification of SCLC
por: Raso, Maria Gabriela, et al.
Publicado: (2021)

From Bench to Bedside: Attempt to Evaluate Repositioning of Drugs in the Treatment of Metastatic Small Cell Lung Cancer (SCLC)
por: Lohinai, Zoltan, et al.
Publicado: (2016)

Protein production, crystallization and preliminary crystallographic analysis of the four N-terminal immunoglobulin domains of Down syndrome cell adhesion molecule 1. Corrigendum
por: Cheng, Linna, et al.
Publicado: (2016)

Limitations of the death certificate only index as a measure of incompleteness of cancer registration
Publicado: (1996)

Erratum
Publicado: (1996)

Allelotype of squamous cell carcinoma of the head and neck: fractional allele loss correlates with survival
Publicado: (1996)

Relationship between expression of topoisomerase II isoforms and intrinsic sensitivity to topoisomerase II inhibitors in breast cancer cell lines
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_1rhpe9gfkta3g5f9mmo9e46thc